---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-097726"
form_type: "8-K"
ticker: "ISPC"
cik: "0001558569"
company_name: "iSpecimen Inc."
filed_at: "2026-09-04T20:48:58+00:00"
generated_at: "2026-09-04T20:50:10.203314+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# iSpecimen to acquire Foldlab AI assets for $4.5M; $2M cash + $2.5M stock

## Summary
- Deal: $4.5M total - $2M cash ($750K at close + $1.25M milestone payments) and $2.5M in stock.
- Assets: Disease-Associated Protein Discovery AI Agent and Disease Trend Prediction/Monitoring AI Model.
- Closing conditions: stockholder approval, Nasdaq listing approval, regulatory consents; proxy to be filed.
- Milestone payments tied to delivery/testing/acceptance; no payment for partial performance.
- Stock consideration in 5-year escrow/lock-up with no leak-out; voting rights agreement.

## SEC filing metadata
- accession: 0001213900-26-097726
- form_type: 8-K
- ticker: ISPC
- cik: 0001558569
- company_name: iSpecimen Inc.
- filed_at: 2026-09-04T20:48:58+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1558569/000121390026097726/0001213900-26-097726-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1558569/000121390026097726/ea0304738-8k_ispecimen.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-097726
- JSON: https://secwatch.observer/filing/0001213900-26-097726.json
- Plain text: https://secwatch.observer/filing/0001213900-26-097726.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.